| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1329 | |
| Phytochemical name or plant extracts | ChalcEA (2',4'-dihydroxy-6-methoxy-3,5-dimethylchalcone) | |
| PMID | 29035298 | |
| Literature evidence | These results suggest that the new ChalcEA derivatives could serve as the lead compound for potent ER? inhibitor in the fight against breast cancer. | |
| IUPAC name | (E)-1-(2,4-dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-phenylprop-2-en-1-one | |
| Phytochemicals’ class or type of plant extracts | Chalcone | |
| Source of phytochemicals or plant Extracts | Eugenia aquea | |
| Geographical availability | Borneo, Jawa, Lesser Sunda Is., Malaya, Maluku, New Guinea, Queensland, Sulawesi, Sumatera | |
| Plant parts | Leaves | |
| Other cancers | Breast cancer, Lung cancer | |
| Target gene or protein | ERα , Caspase 3 | |
| Gene or Protein evidence | ChalcEA derivatives could serve as the lead compound for potent ERα inhibitor in the fight against breast cancer. ChalcEA with the binding energy of -6.53 kcal/mol could compete better than 4-methyl benzenesulfonamide (-6.43 kcal/mol) as an inhibitor of caspase-3. | |
| Target pathways | Induce apoptosis through activation of the caspase cascade signaling pathway. | |
| IC50 | 74.5 µg/mL (250 µM) against MCF-7 142.58 ± 4.6 µMagainst T47D | |
| Potency | NA | |
| Cell line/ mice model | T47D, A549, MCF-7. | |
| Additional information | MD simulations showed that ChalcEA destabilized the conformation of His524, a remarkable behavior of a known hERa antagonist, including 4-OHT, ChalcEA with the binding energy of -6.53 kcal/mol could compete better than 4-methyl benzenesulfonamide (-6.43 kcal/mol) as an inhibitor of caspase-3. | |
| PubChem ID | 10424762 | |
| Additional PMIDs | 31807030 32269629 | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:601415-1 | |
| Safety | NA |